Simultaneous multi-vessel subacute stent thromboses in zotarolimus-eluting stents

Yong Hyun Kim, Soon Yong Suh, Seong Hwan Kim, Sang Yup Lim, Seung Young Roh, Ji Bak Kim, Woo Hyuk Song, Jeong Cheon Ahn

    Research output: Contribution to journalArticlepeer-review


    Despite its low incidence, stent thrombosis (ST) is one of the most dreaded complications of percutaneous coronary intervention. Endeavor (Medtronics Europe SA) is a new zotarolimus-eluting stent (ZES) with a favorable safety profile that was reported in early and ongoing trials. However, few lethal stent thromboses related to this new drug eluting stent (DES) have been reported. We experienced a case of simultaneous subacute ZES thromboses, 6 days after stent implantations in the proximal left anterior descending artery and the proximal right coronary artery (RCA).

    Original languageEnglish
    Pages (from-to)243-246
    Number of pages4
    JournalKorean Circulation Journal
    Issue number5
    Publication statusPublished - 2010 May


    • Drug-eluting stents
    • Stents
    • Thrombosis
    • Zotarolimus

    ASJC Scopus subject areas

    • Internal Medicine
    • Cardiology and Cardiovascular Medicine


    Dive into the research topics of 'Simultaneous multi-vessel subacute stent thromboses in zotarolimus-eluting stents'. Together they form a unique fingerprint.

    Cite this